Stocklytics Platform
Asset logo for symbol QGEN
QIAGEN NV
QGEN49
$42.140.00%$0.00
Asset logo for symbol QGEN
QGEN49

$42.14

0.00%
Key Stats
Open$42.07
Prev. Close$42.12
EPS0.34
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range41.80
42.14
52 Week Range34.74
47.44
Ratios
EPS0.34
Fundamentals
Payout Ratio-
Industry average yield2.84%
Last Dividend pay dateJan 30, 2024
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

QGEN-
US Healthcare Sector-
US Market-
check_circle

QGEN / Market

QGEN exceeded the US Market which returned 0.31% over the last twenty four hours.
warning

QGEN / Healthcare Sector

QGEN lose to the US Healthcare sector which returned 3.03% over the last twenty four hours.

QIAGEN NV (QGEN) Statistics

QIAGEN NV (QGEN) is a leading provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company's products enable researchers to analyze the building blocks of life - DNA, RNA and proteins - as well as determine the genetic causes of diseases and develop personalized treatments. QIAGEN NV has a global presence, with operations in more than 35 countries and a diverse customer base that includes academic institutions, pharmaceutical companies, and clinical laboratories. The company is headquartered in Venlo, the Netherlands.
When it comes to stock statistics, QIAGEN NV has consistently shown strong performance. The company's stock price has experienced steady growth over the past few years, outperforming the broader market. QIAGEN NV's valuation metrics are also impressive, with a favorable price-to-earnings ratio and price-to-sales ratio. This indicates that the company is undervalued compared to its industry peers. Additionally, QIAGEN NV's fundamentals are solid, with a healthy balance sheet and strong cash flow. The company has a strong track record of generating revenue and profits, making it an attractive investment option.
add QIAGEN NV to watchlist

Keep an eye on QIAGEN NV

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How much debt does QIAGEN NV (QGEN) have?

QIAGEN NV (QGEN) has a total debt of $1.46B. The net debt, which accounts for cash and cash equivalents against the total debt, is $867.98M.
help

How has QIAGEN NV (QGEN) stock's performance compared to its sector and the market over the past year?

Over the past year, QIAGEN NV (QGEN) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 37.77%, QIAGEN NV has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 74.16%, it has fallen short of the market average. This comparison highlights QIAGEN NV's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of QIAGEN NV (QGEN) stock?

The PE (Price to Earnings) ratio of QIAGEN NV (QGEN) is currently 123.94. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of QIAGEN NV (QGEN) stock?

The Earnings Per Share (EPS) for QIAGEN NV (QGEN), calculated on a diluted basis, is $0.34. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of QIAGEN NV (QGEN) stock?

The operating margin for QIAGEN NV (QGEN) is -32.31%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of QIAGEN NV (QGEN) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of QIAGEN NV (QGEN) is $723.86M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level